Neuromuscular taping reduces blood pressure in systemic arterial hypertension


April 2018


Medical Hypotheses 166 (2018) 32 34

M.Shah (a,b), P.O.O. Julu (a,b), J.A. Monro (a), J.Coutinho (c), C.Ijeh (a), B.K. Puri (d)

a ) Breakspear Medical Group, Hemel Hempstead, Hertfordshire, UK

b ) Queen Mary University of London and the William Harvey Research Institute, Barts and the London School of Medicine, UK

c ) School of Physiotherapy, Escola Superiror de Saude/Politecnico do Porto, Portugal.

d ) Department of Medicine, Imperial College London, UK

Medical Hypotheses 166 (2018) 32 34


Over the past three years, Aneid UK Ltd has been working with Breakspear Medical Group on a joint research program to investigate the potential applications of neuromuscular tape on the autonomic nervous system. The autonomous nervous system is the part of the nervous system responsible for control of the bodily functions not consciously directed, such as breathing, the heartbeat, and digestive processes.

The first publication generated by this collaboration has been published in the April issue of Medical Hypotheses. In their collaboration, the researchers were aware that a dysfunction of the autonomic nervous system can result in morbidity, such as in systemic arterial hypertension. The following hypothesis was tested, can neuromuscular taping reduce blood pressure in system arterial hypertension.

As outlined in the study, seven patients with systemic arterial hypertension were taped for five days between C1 and T2. Significant reductions in blood pressure were noted and the effects lasted for up to five (5 days) after removal of the neuromuscular tape (EU Class I Medical Device/Cure Tape brand).

The importance of this application is that there are hypertension patients that are not responsive to medication. The objective is to determine if the application of neuromuscular tape can support a non-pharmaceutical solution by modulating the autonomous nervous system.